Edward Rosfjord

2.7k citations
39 papers · 1.9k indexed · 1 hit paper · h-index 19
Topics
HER2/EGFR in Cancer Research (9 papers)Monoclonal and Polyclonal Antibodies Research (9 papers)Cancer-related Molecular Pathways (5 papers)

In The Last Decade

Edward Rosfjord

39 papers receiving 1.8k citations

Hit Papers

Antitumor Activity of HKI-272, an Orally Active, Irrevers...20042026201120182004100200300400500

Peers

Edward Rosfjord
Comparison fields: 5 of 85
  • Oncology 1.0k
  • Molecular Biology 938
  • Pulmonary and Respiratory Medicine 383
  • Radiology, Nuclear Medicine and Imaging 358
  • Cancer Research 271
Replace Mathias Schmidt with:
Mathias Schmidt Germany
Joan T. Garrett United States
Erwin R. Boghaert United States
Anne T. Truesdale United States
Neil A. O’Brien United States
Thomas Holbro Switzerland
Anke Baum Austria
Ayana Sawai United States
Ben Markman Australia
Alan Berezov United States
Edward Rosfjord relative to Mathias Schmidt Germany Mathias Schmidt's profile →
Citations per field
00.5×3.1×
Mathias Schmidt · 1×
Citations per year

Countries citing papers authored by Edward Rosfjord

Since Specialization
Citations

This map shows the geographic impact of Edward Rosfjord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Rosfjord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Rosfjord more than expected).

Fields of papers citing papers by Edward Rosfjord

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Rosfjord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Rosfjord. The network helps show where Edward Rosfjord may publish in the future.

Co-authorship network of co-authors of Edward Rosfjord

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Rosfjord. A scholar is included among the top collaborators of Edward Rosfjord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Rosfjord. Edward Rosfjord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 1
4 19
5 113
6 155
7 21
8 123
9 25
10 39
11 1
12 25
13 73
14 1
15 80
16 33
17 18
18 26
19 31
20 11

About Edward Rosfjord

Edward Rosfjord is a scholar working on Oncology, Immunology and Allergy and Biotechnology, having authored 39 papers that have together received 1.9k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Oncology (1.0k citations), Cancer Research (271 citations) and Radiology, Nuclear Medicine and Imaging (358 citations). Edward Rosfjord has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Robert B. Dickson, Sridhar K. Rabindran, Angie Rizzino, Judy Lucas, Yu‐Fen Wang, M. Brawner Floyd, Bernard D. Johnson, Hwei‐Ru Tsou, William Hallett and Marvin F. Reich. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026